Jiangsu gdk Biotechnology Co Ltd Class A 688670
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 17.42
- Day Range
- CNY 17.27–17.79
- 52-Week Range
- CNY 15.01–52.41
- Bid/Ask
- CNY 17.73 / CNY 17.74
- Market Cap
- CNY 2.18 Bil
- Volume/Avg
- 440,027 / 724,364
Key Statistics
- Price/Earnings (Normalized)
- 23.74
- Price/Sales
- 55.27
- Dividend Yield (Trailing)
- 1.13%
- Dividend Yield (Forward)
- 1.13%
- Total Yield
- 1.13%
Company Profile
Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 451
- Website
- http://www.gdkbio.com
Comparables
Valuation
|
Metric
|
688670
|
300841
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.74 | 13.86 | 43.84 |
Price/Book Value | 1.62 | 2.30 | 2.47 |
Price/Sales | 55.27 | 5.12 | 5.93 |
Price/Cash Flow | 75.34 | 12.57 | 26.89 |
Price/Earnings
688670
300841
300142
Financial Strength
|
Metric
|
688670
|
300841
|
300142
|
|---|---|---|---|
Quick Ratio | 1.40 | 4.14 | 2.46 |
Current Ratio | 3.34 | 4.49 | 2.85 |
Interest Coverage | −80.32 | 119.95 | 47.19 |
Quick Ratio
688670
300841
300142
Profitability
|
Metric
|
688670
|
300841
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | −4.87% | — | 3.37% |
Return on Equity (Normalized) | −5.91% | — | 5.57% |
Return on Invested Capital (Normalized) | −5.65% | — | 3.91% |
Return on Assets
688670
300841
300142
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Rbtbgfzk | Yqd | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xgbshbr | Fmzmkvd | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bdsqxhs | Cswgjw | $108.2 Bil | |
MRNA
| Moderna Inc | Rbptbpjxr | Mcqh | $50.9 Bil | |
ARGX
| argenx SE ADR | Bvkcxzx | Xnbb | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Bsygrqwl | Hfkd | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Dmlmvxs | Ftpbby | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Dqdblpjb | Lmwkm | $14.6 Bil | |
INCY
| Incyte Corp | Bsmlgxrd | Xkqvwd | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jywcdcttnq | Dzhvynx | $12.3 Bil |